Cormorant Asset Management, LP

Insider Reports History

Entity
Company
Location
200 Clarendon Street, 52 Nd Floor, Boston, MA
Signature
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cormorant Asset Management, LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. 10%+ Owner Ordinary Shares 69.5M $642M $9.24 Sep 18, 2023 Indirect
Ambrx Biopharma, Inc. 10%+ Owner Common Stock 11.2M $110M $9.82 Oct 23, 2023 Indirect
EyePoint Pharmaceuticals, Inc. 10%+ Owner Common Stock 8.33M $103M $12.36 May 6, 2024 Indirect
Monte Rosa Therapeutics, Inc. Former 10% Owner Common Stock 3.2M $60.8M $19.00 Jun 28, 2021 Indirect
Corbus Pharmaceuticals Holdings, Inc. 10%+ Owner Common Stock 2.38M $52.8M $22.23 Sep 20, 2024 Indirect
Aerovate Therapeutics, Inc. Former 10% Owner Common Stock 2.03M $39.6M $19.50 Jul 2, 2021 Indirect
Verve Therapeutics, Inc. Former 10% Owner Common Stock 984K $9.84M $10.00 Jun 21, 2021 Indirect
Immuneering Corp 10%+ Owner Class A Common Stock 2.9M $8.6M $2.97 Apr 1, 2024 Indirect
Tyra Biosciences, Inc. Former 10% Owner Common Stock 1.07M $7.04M $6.58 Sep 17, 2021 Indirect
Icosavax, Inc. Former 10% Owner Common Stock 426K $6.68M $15.67 Aug 2, 2021 Indirect
Ventyx Biosciences, Inc. Former 10% Owner Common Stock 1.41M $2.99M $2.12 Oct 25, 2021 Indirect
Vigil Neuroscience, Inc. Former 10% Owner Common Stock 617K $2.31M $3.75 Jan 11, 2022 Indirect
Pyxis Oncology, Inc. Former 10% Owner Common Stock 1.12M $1.57M $1.40 Oct 13, 2021 Indirect
Elevation Oncology, Inc. Former 10% Owner Common Stock 2.23M $1.14M $0.51 Jun 29, 2021 Indirect
Reneo Pharmaceuticals, Inc. 10%+ Owner Class A Common Stock 1.84M Oct 4, 2024 Indirect
BioAge Labs, Inc. Former 10% Owner Common Stock 1.63M Sep 27, 2024 Indirect
BRIGHT MINDS BIOSCIENCES INC. 10%+ Owner Common Shares 1.06M Nov 4, 2024 Indirect
Aerovate Therapeutics, Inc. Former 10% Owner Series A Convertible Preferred Stock 0 Jul 2, 2021 Indirect
BioAge Labs, Inc. Former 10% Owner Series D Redeemable Convertible Preferred Stock 0 Sep 27, 2024 Indirect
Elevation Oncology, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 Jun 29, 2021 Indirect
GreenLight Biosciences Holdings, PBC Other* Common Stock 0 $0.30 Jul 20, 2023 Indirect
Icosavax, Inc. Former 10% Owner Series B-1 Convertible Preferred Stock 0 Aug 2, 2021 Indirect
Monte Rosa Therapeutics, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 $2.00 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. Former 10% Owner Series C Convertible Preferred Stock 0 Jun 28, 2021 Indirect
Pyxis Oncology, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 Oct 13, 2021 Indirect
Tyra Biosciences, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 Sep 17, 2021 Indirect
Ventyx Biosciences, Inc. Former 10% Owner Series A Convertible Preferred Stock 0 Oct 25, 2021 Indirect
Ventyx Biosciences, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 Oct 25, 2021 Indirect
Verve Therapeutics, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 Jun 21, 2021 Indirect
Vigil Neuroscience, Inc. Former 10% Owner Series B Convertible Preferred Stock 0 Jan 11, 2022 Indirect

Insider Reports Filed by Cormorant Asset Management, LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DRUG BRIGHT MINDS BIOSCIENCES INC. Nov 4, 2024 1 $4M 4 Nov 6, 2024 10%+ Owner
DRUG BRIGHT MINDS BIOSCIENCES INC. Oct 15, 2024 11 $3.23M 4 Oct 17, 2024 10%+ Owner
DRUG BRIGHT MINDS BIOSCIENCES INC. Oct 15, 2024 0 $0 3 Oct 17, 2024 10%+ Owner
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 15, 2024 10%+ Owner
BIOA BioAge Labs, Inc. Sep 27, 2024 3 $8.1M 4 Oct 1, 2024 Former 10% Owner
BIOA BioAge Labs, Inc. Sep 25, 2024 0 $0 3 Sep 25, 2024 10%+ Owner
CRBP Corbus Pharmaceuticals Holdings, Inc. Sep 20, 2024 6 $7M 4 Sep 24, 2024 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. May 6, 2024 2 $10.1M 4 May 8, 2024 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. Apr 18, 2024 2 $10.5M 4 Apr 22, 2024 10%+ Owner
IMRX Immuneering Corp Apr 1, 2024 8 -$1.16M 4 Apr 3, 2024 10%+ Owner
IMRX Immuneering Corp Mar 14, 2024 5 -$2.75M 4 Mar 18, 2024 10%+ Owner
CRBP Corbus Pharmaceuticals Holdings, Inc. Mar 7, 2024 10 $23.3M 4 Mar 11, 2024 10%+ Owner
CRBP Corbus Pharmaceuticals Holdings, Inc. Feb 2, 2024 1 $14.3M 4 Feb 6, 2024 10%+ Owner
CRBP Corbus Pharmaceuticals Holdings, Inc. Jan 26, 2024 14 $9.11M 4 Jan 30, 2024 10%+ Owner
CRBP Corbus Pharmaceuticals Holdings, Inc. Jan 26, 2024 0 $0 3 Jan 30, 2024 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. Jan 9, 2024 2 $17.1M 4 Jan 11, 2024 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. Dec 8, 2023 1 $10M 4 Dec 12, 2023 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. Dec 4, 2023 17 $41.9M 4 Dec 6, 2023 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. Dec 4, 2023 0 $0 3 Dec 6, 2023 10%+ Owner
AMAM Ambrx Biopharma, Inc. Oct 23, 2023 1 $9.14M 4 Oct 25, 2023 10%+ Owner
AMAM Ambrx Biopharma Inc. Sep 15, 2023 2 $19.6M 4 Sep 19, 2023 10%+ Owner
GRNA GreenLight Biosciences Holdings, PBC Jul 20, 2023 1 $0 4 Jul 24, 2023 Other*
GRNA GreenLight Biosciences Holdings, PBC May 29, 2023 0 $0 3 Jun 8, 2023 Other*
IMRX Immuneering Corp Apr 20, 2023 0 $0 3 Apr 24, 2023 10%+ Owner
AMAM Ambrx Biopharma Inc. Apr 18, 2023 3 $59M 4 Apr 20, 2023 10%+ Owner
AMAM Ambrx Biopharma Inc. Apr 13, 2023 3 $25.3M 4 Apr 17, 2023 10%+ Owner
AMAM Ambrx Biopharma Inc. Mar 14, 2023 3 $10.2M 4 Mar 16, 2023 10%+ Owner
AMAM Ambrx Biopharma Inc. Mar 3, 2023 0 $0 3 Mar 13, 2023 10%+ Owner
VIGL Vigil Neuroscience, Inc. Jan 11, 2022 2 $0 4 Jan 13, 2022 Former 10% Owner
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 10%+ Owner
VTYX Ventyx Biosciences, Inc. Oct 25, 2021 4 $10M 4 Oct 27, 2021 Former 10% Owner
VTYX Ventyx Biosciences, Inc. Oct 20, 2021 0 $0 3 Oct 20, 2021 10%+ Owner
PYXS Pyxis Oncology, Inc. Oct 13, 2021 3 $7.2M 4 Oct 15, 2021 Former 10% Owner
PYXS Pyxis Oncology, Inc. Oct 7, 2021 0 $0 3 Oct 7, 2021 10%+ Owner
TYRA Tyra Biosciences, Inc. Sep 17, 2021 3 $5M 4 Sep 21, 2021 Former 10% Owner
TYRA Tyra Biosciences, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 10%+ Owner
IMRX Immuneering Corp Aug 3, 2021 3 $8.25M 4 Aug 5, 2021 Former 10% Owner
ICVX Icosavax, Inc. Aug 2, 2021 2 $0 4 Aug 4, 2021 Former 10% Owner
IMRX Immuneering Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 10%+ Owner
ICVX Icosavax, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jul 2, 2021 3 $7M 4 Jul 7, 2021 Former 10% Owner
ELEV Elevation Oncology, Inc. Jun 29, 2021 3 $4M 4 Jul 1, 2021 Former 10% Owner
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 4 $11.4M 4 Jun 30, 2021 Former 10% Owner
ELEV Elevation Oncology, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 3 $5.23M 4 Jun 23, 2021 Former 10% Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner